Tumour ‐derived lactate mediates METTL3 lactylation to increase the binding capacity of RNA, and METTL3 lactylation in TIMs promotes m6A‐mediated immunosuppression in the tumour microenvironment (TME).47 Here, METTL3 is linked to neoplasm.